OECs transplantation results in neuropathic pain associated with BDNF regulating ERK activity in rats following cord hemisection by Bing-Chen Lang et al.
Lang et al. BMC Neuroscience 2013, 14:80
http://www.biomedcentral.com/1471-2202/14/80RESEARCH ARTICLE Open AccessOECs transplantation results in neuropathic pain
associated with BDNF regulating ERK activity in
rats following cord hemisection
Bing-Chen Lang1,2†, Zhuo Zhang4†, Long-Yun Lv3, Jin Liu2, Ting-Yong Wang3, Ling-Hui Yang2, Da-Qing Liao2,
Wen-Sheng Zhang2* and Ting-Hua Wang2,3,5*Abstract
Background: The olfactory ensheathing cells (OECs) derived from olfactory bulb (OB) may improve motor function
after transplantation in injured spinal cord. However, the effects of OEC transplantation on sensory function have
not been reported yet. The purpose of this study is to investigate whether OEC transplantation could affect the
sensory function and to analyze the underlying mechanism.
Results: OEC transplantation into the hemisected spinal cords can result in hyperalgesia, indicated by radiant and
mechanical stimuli towards the plantar surface in rats. This could be associated with upregulation of Brain Derived
Neurotrophic Factor (BDNF), indicated by RT-PCR. Immunofluorecent staining showed that BDNF was mainly
located in the neurons of the laminas I and II of the dorsal horn. Moreover, a notable upregulation on the level of
p-ERK (phosphorylation of extracellular signal-regulated kinase), the downstream molecule of BDNF, was detected
by using Western Blot. These findings indicate that the increased BDNF level associated with the p-ERK was possibly
involved in neuropathic pain in hemisected spinal cord subjected to OEC transplantation.
Conclusions: The transplantation of OECs may induce the noticeable pain hypersensitivity in rats after hemisected
spinal cord injury, and the possible mechanism may be associated with the phosphorylation of ERK and the
activated BDNF overexpression.
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HyperalgesiaBackground
To make the neuronal regeneration to eventual functional
recovery after spinal cord injury (SCI), various treatments
including surgical, pharmacological, and neurophysiologic
approaches have been performed. Especially, cell trans-
plantation with hypotoxicity and high effectiveness could
be a promising strategy for the treatment of SCI.
As a special type of neuroglial cells derived from the
olfactory bulb, olfactory ensheathing cells (OECs), are
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reproduction in any medium, provided the orCompared with the Schwann cells, the OEC possess
higher migration ability and higher ability of integration
with nerve axons and other neuroglial cells [1-3]. Report-
edly, OECs can secrete various neurotrophins such as
platelet derivation growth factor (PDGF), brain-derived
neurotrophic factor (BDNF) [4,5], nerve growth factor
(NGF) [6] and neurotrophin-4/5 [7]. In an injured spinal
cord, the transplanted OECs have a neuroprotective effect
on descending cortical and brain stem neurons [8,9],
suggesting the effect of OECs on the improvement of
motor function. However, it is still unknown whether the
treatment of OEC transplantation could work well on the
sensory function.
In this experiment, the mechanical and thermal hyper-
algesia behaviors of rats with hemisected spinal cord injury
(hSCI) were observed after OEC transplantation. Then wed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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correlated with the phosphorylation of ERK and the up-
regulation of BDNF.Results
Identification of OECs in vitro
After 24 h of culturing, the adherent cells were in
rounded shape and uniform distribution. After 3 days of
culture, the cell bodies were amplified obviously and
most of them formed triangles with two or three pro-
cesses. After 5–7 days of culture, the characteristics of
OECs in vitro were shown, and the cell processes were
elongated remarkably and they contact mutually to form
a network (Figure 1A). Enzyme immunochemical stain-
ing of the cultured cells were positive for neurotrophin
p75 surface receptor, identified as OECs. The purity
of OECs is higher than 95%. These cells were brown
as a DAB reaction product was present in these cells
(Figure 1B). In addition, OECs derived from the GFP
transgenic mice could emit green fluorescence (Figure 1C).
Based on red fluorescent staining under incubation by p75
antibody, we also identified the cultured cells as OECs
in vitro (Figure 1D).Evaluation on Nociceptive tests
In sham-operated rats, the paw withdrawal latency (PWL)
and paw withdrawal thresholds (PWT) were recorded
separately.Figure 1 Identification of OECs in vitro. The cultured OECs were shown
surface receptor p75 (B, Brown staining with DAB). The GFP-OECs cells whi
fluorescence confirmed that the GFP cells can express p75 (D).Thermal stimuli
In the nociceptive evaluation of thermal stimuli, these
asterisks indicate that the left PWL of the OEC trans-
plantation group (4.41 ± 2.38 s) was significantly lower
than those of hSCI group (7.42 ± 4.20s) (*P < 0.05) and
the sham group (9.06 ± 1.28 s) (***P < 0.001). There was
no significant difference in left PWL between the sham
group and the hSCI group. The quantitative analysis is
shown in Figure 2A.Mechanical stimuli
By using the pressure stimuli expressed by grams to the
injury-side hind paws of rats in each group, we found that
the PWTs of sham group (192.67 ± 39.25 g) were signifi-
cantly higher than those of the hSCI group (113.33 ±
49.24 g) (***P < 0.001), and the OEC treatment group
(93.33 ± 74.63 g) exhibited the lowest level (***P < 0.001).
The quantitative analysis is shown in Figure 2B.Survival and migrating of OECs in vivo
To confirm the survival of OECs with spinal cord injury,
GFP (green fluorescent protein)-positive OECs were ob-
served. As shown in Figure 3A and C, GFP-labeled OECs
with fluorescence were seen in the spinal cord. The results
confirmed that the implanted OECs were capable of
surviving and migration in the spinal cord till one month
after injury, compared with the situation of the hSCI
group without cells transplantation (Figure 3B).in A. The cells exhibited positive brown staining for neurotrophin
ch emitting green fluorescence were seen in C, simultaneously, the red
Figure 2 Evaluations on Nociceptive Tests. In the nociceptive evaluation of thermal stimuli, these asterisks indicate that the left paw
withdrawal latency (PWL) of the OEC transplantation group was significantly lower than those of the injury group (*P < 0.05) and the sham group
(***P < 0.001) (A). In the nociceptive evaluation of thermal stimuli, the left paw withdrawal thresholds (PWT) of sham group were significantly
higher than those of the injury group (***P < 0.001), while the PWTs of the OEC transplantation group were significant lower than the sham
group (***P < 0.001) (B).
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In order to determine the change of BDNF-positive cells,
we performed the immunofluorescent staining by using
BDNF antibodies. The secondary antibodies were conju-
gated to the fluorescent marker Cy-3, which emits red
fluorescence to be observed by fluorescent microscope.
Compared with the sham group (Figure 3D) and the
hSCI group (Figure 3E), the number of BDNF-positive
cells was increased in the OECs transplantation group
(Figure 3F). The quantitative analysis on the comparison
of the numbers of BDNF-positive cells is shown in
Figure 3G, which shows significant difference between
the OECs transplantation group and the hSCI group
(*P < 0.05).
The images indicated BDNF-positive cells were present
not only in OECs engrafted with GFP fluorescence
(Figure 3F), but also in neurons in the superficial layer
of dorsal horn surrounding the spinal cord injury.BDNF co-expression in engrafted OECs and host neurons
To identify the co-localization of BDNF in host neurons
and engrafted OECs, the immunofluorecent double-label
staining was performed by using anti-BDNF, anti-NeuN
(neuronal marker), and anti-TrkB separately. Double-
label staining showed that the engrafted OECs can express
BDNF after transplantation (Figure 4A-4D). BDNF-
positive cells were labeled simultaneously by anti-NeuN.
This confirmed that the cells labeled by BDNF staining
are neurons in the host spinal cord (Figure 4E-4H). In
addition, the neurons labeled by BDNF were also found
to express TrkB, the functional receptor of BDNF
(Figure 4I-4L).
The mRNA changes of BDNF in RT-PCR
The mRNA expressions for BDNF were detected in the
sham group, the hSCI group and the OECs transplant-
ation rats. Significant difference between the hSCI group
Figure 3 Survival and migrating of OECs in vivo, and localization of BDNF. Compared with the situation of injured control group (B),
implanted OECs had the capability of surviving in the injured spinal cord after implantation (A). The OEC with green fluorescence around the site
of injury were showed in C, indicating the transplanted cells could survive and migrate in spinal cord till one month after injury. Simultaneously,
neurons in the dorsal horn could express BDNF,which emit red fluorescence (D-F). The quantitative analysis was showed in G.
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21st day (*P < 0.05), but not at other time points. There-
fore, OEC transplantation could significantly upregulate
the BDNF expression in the spinal cord after injury
(Figure 5A, Figure 5B).
Changes of ERK and p-ERK expressions detected by
Western blot
ERK activation was determined by Western blotting.
Compared with the sham group, there were no changes
on the expressions of ERK following SCI Figure 6A.
However, the OEC administration resulted in a signifi-
cant increase on the level of p-ERK in the spinal cord
both on the 14th day and the 21st day (*P < 0.05)
(Figure 6B-6C).
Discussion
The results show that the OECs from olfactory bulb may
induce hyperalgesia when they were transplanted into the
hemisected spinal cord in rats. And this phenomenonseemed to be associated with the activation of ERK and
the increase of BDNF level, indicated by RT-PCR and
Western Blot.
Currently, cell transplantation is one novel therapeutic
strategy for the treatment of SCI. As one type of glial
cells ensheathed in the olfactory axons, OECs are fea-
tured by the function of promoting the axonal regener-
ation. Several studies emphasized the optimal role of
OECs in the treatment of SCI, which may induce func-
tion repair for improving locomotor level [8,10-13] and
promoting axonal regeneration [14,15], in the paraplegic
[10], transected [13,14], contused [8] SCI models and
multiple lumbar rhizotomy [16]. Moreover, the introduc-
tion of OECs can remyelinate the demyelinated axons in
the lesions of the animal spinal cord [17-19]. Unfortu-
nately, however, there is no evidence to reveal how this
transplantation affects the sensory function. Therefore,
we aim to test whether the treatment of OEC transplant-
ation in rat hSCI model may affect the regulation of
sensory function as the motor function.
Figure 4 Identification of BDNF expression in transplanted OECs and host neurons. The distribution of nucleus would be showed in DAPI
staining. It is showed that OECs can express BDNF after transplantation (A-D). Meanwhile, the images also showed that the BDNF expression was
concomitantly occurred in neurons (E-H), while these neurons has co-expresseion of TrkB receptor (I-L).
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showed that the OECs treatment group had lower PWL
than the untreated group. This result suggests that the
OEC transplantation into spinal cord injured rats may
induce obvious hyperalgesic responses. For this reason,
the analgesic approach should be developed when we
consider the OEC transplantation therapy.
To investigate the underlying mechanism of the
allodynia following OEC implantation, we determined
the expressions of BDNF and ERK. Consequently, BDNF
expression in injured spinal cord was greatly increasedFigure 5 mRNA changes of BDNF in RT-PCR. OECs transplantation could
spinal cord after OEC transplantation (A). The quantitative analysis was sho
between hemisected group and OECs transplantation group (*P < 0.05).in OEC-transplanted rats on 21st day and BDNF was
located in neurons of the superficial layer in the dorsal
horn. It is known that the productions of growth factors
(NGF, BDNF, and GDNF) and the expressions of corre-
sponding receptors may contribute to axonal regener-
ation following OEC transplantation [5]. BDNF as one
type of the neurotrophin family of growth factors can
not only support the survival of the existing neurons
and promote the growth and differentiation of new neu-
rons and synapses [20,21], but also trigger the pain in
sciatic nerve separation model [22] and ligation modellargely upregulate the BDNF expression on the 21th day ininjured
wed in B, indicating the significant difference of Relative OD Value
Figure 6 (See legend on next page.)
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Figure 6 Changes of ERK and p-ERK in OEC treated rats. Compare with the sham group and the injury group, OECs graft can lead to a
significant increase on the p-ERK expression both on the 14th day and the 21st day while there were no differences on the ERK expression
among three groups (A). The quantitative analyses for ERK and p-ERK on the 14th day and the 21st day were showed in B-C. The images
indicated that the p-ERK expression increase significantly (*P < 0.05) on the 14th day (B) and the 21st day (C).
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was performed to observe the expression of BDNF at the
injured segment, and the red fluorescence which sym-
bolized “BDNF positive” was found in the superficial
layer of dorsal horn. Simultaneously, the upregulation of
BDNF expression was also confirmed. These results in-
dicated that OEC transplantation could increase BDNF
expression in sensory neurons of the dorsal horn,
which may contribute to the observed phenomena like
hyperalgesia.
More importantly, we also found the p-ERK (phosphor-
ylation of extracellular signal-regulated kinase) level was
increased in the injured spinal cord after OEC transplant-
ation. The potential correlation of the activation of ERK
following spinal neuron injury with the pain hypersensi-
tivity and central sensitization was well documented
[24,25]. Within a minute after a noxious stimulus, many
p- ERK-positive neurons were observed, predominantly
in laminas I and II of the ipsilateral dorsal horn [26],
and the phosphorylation of ERK occurring in the noci-
ceptive neurons may contribute to persistent inflamma-
tory and neuropathic pains [27]. In present study, we
observed the activation of ERK following OEC trans-
plantation, which may be related to hyperalgesia. In this
observation, several events including behavior and mol-
ecule have occurred at different time points. Reportedly,
the ERK phosphorylation may be a reason for the in-
crease of BDNF [28]. Therefore, the increase of ERK
phosphorylation on the 14th day may induce the in-
crease of BDNF level on the 21st day. As the behavioral
changes were generally resulting from the cellular and
molecular changes, hyperalgesia was found after 1 month.
Together, the phosphorylation of ERK results in the
upregulation of BDNF, and eventually gives rise to the
behavioral hyperalgesia.
We also found that BDNF was expressed both in
OECs and in host neurons. As the neurons with BDNF
staining are expressing TrkB simultaneously, probably
the BDNF released from OECs could be enrolled into
neurons by TrkB receptor. These could underline someTable 1 Numbers of animal in each group
Group PCR
1st day 3rd day 14th day 21st day
SCI 5 5 5 5
OEC 5 5 5 5
Sham 5 5 5 5linkage by BDNF for the consequent hyperalgesia be-
tween transplanted OECs and host neurons.
In summary, these findings may provide novel insight
into the hyperalgesia responses following OEC transplant-
ation. In using OEC transplantation for the treatment of
SCI, it is useful to consider the inhibition of ERK phos-
phorylation and BDNF blockage to relieve the nociceptive
behaviors.
Conclusion
The transplantation of OECs which can promote axonal
regeneration and functional recovery in previous studies
may induce noticeable pain hypersensitivity following
hSCI. This could be associated with the overexpression of
BDNF in the injured spinal cord and the phosphorylation
of ERK. The current findings may indicate some thera-
peutic strategies involving the inhibition of ERK activation
or BDNF blockage to treat SCI more correctly and effica-
ciously in future clinical practice.
Methods
Animal and grouping
Adult Sprague–Dawley rats weighing 180–220 g, obtained
from the Animal Center of the Sichuan University, were
used in this experiment. The animals were divided into
three groups randomly (Table 1): Group A rats were
underwent hemisected spinal cord injury at the eighth
thoracic (T10) cord level, Group B rats were received
OECs transplantation after injury, Group C rats were as
the sham group (rats were underwent neither SCI nor
transplant injections).
Ethics statement
The animal study proposal was legally approved by the
Animal Care & Welfare Committee of West China
Hospital, Sichuan University with the approval number:
201. All the experiment conforms to the Guide for the
Care and Use of Laboratory Animals published by the
US National Institutes of Health.Western blotting Behavior and IHC
28th day 14th day 21st day 28th day
5 5 5 5
5 5 5 5
5 5 5 5
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in vitro
The GFP (green fluorescent protein) transgenic mice
[29] were sterilized by incubation in the 75% alcohol for
1–2 min, and were sacrificed by decapitation subse-
quently. Then the head was moved into the culture
medium (DMEM with Ham’s F12 - 1:1, Gibco). By using
the microscope, the olfactory bulb was dissected and
then transported into the cold 10% FBS medium. After
washing two times by DMED medium, the tissue block
was centrifuged to collect sedimentation. After remov-
ing off the supernatant, new DMEM medium was
added. By using micropipette, the tissue block was dis-
sected into cell suspension. Then the cell pellets of
OECs were placed on a poly-L lysine-coated culture
flask at a concentration of 1 × 106/ml. The culture was
maintained at 37°C with 5% carbon dioxide in an atmos-
phere of 95% humidity. After first 12-h incubation, the
culture media were transferred into another flask and
this process was repeated again for removing the fibro-
blasts. The culture media containing purified OECs
were plated into flask for 7 days, and then were
passaged to amplify the numbers of cells till the 3rd
passage. To identify the character of cultured OECs, the
low-affinity neurotrophin receptor p75NGFR (1:400,
Santa Cruz Biotechnology) was used. Briefly, OECs were
fixed with 4% paraformaldehyde in 0.1 M phosphate-
buffered saline (PBS) for 30 min. For immunohisto-
chemistry, the cells were washed three times in 0.01 M
PBS and then were incubated in 3% hydrogen peroxide
at room temperature for 20 min in order to block the
action of various endogenous peroxidase. After 30 min
immersion in PBS (containing 0.3% Triton X-100 and
5% normal goat serum) at 37°C, they were processed for
an incubation with anti-rabbit p75 (1:400, Santa Cruz
Biotechnology) at 4°C overnight. After washing three
times, goat-anti-rabbit IgG was used for incubation for
2 h at 37°C. After washing, they were reacted with DAB
in hydrogen peroxide. Following staining for 5 min, the
cells were routinely dehydrated. Then the digital images
of the cells were photographed and captured with the
LEICA automatic photo micrographic system. To deter-
mine the purity of OECs, the percentage of P75 positive
cells was counted.
Immunofluorescent staining in vitro
For immunofluorescent staining, the OECs were washed
in PBS for 10 min, blocked in 5% normal goat serum
(NGS, Sigma), and 0.3% Triton X-100 in PBS for 1 hour
at room temperature. Afterward, they were incubated
with rabbit anti-p75 (anti-rabbit, 1:400, Santa Cruz
Biotechnology) in OECs for 2 h at 37°C and then were
incubated overnight at 4°C. After washing three times
and the incubation with fluorescent secondary antibodyIgG (Goat anti-rabbit CY3: red) for 2 h at 37°C, they
were observed under fluorescent microscope. The con-
trol cells were incubated in PBS to replace the primary
antibody.
Hemisected spinal cord injury model and administration
of ciclosporin A
After anesthetization by intraperitoneal injection of 3.6%
chloral hydrate, rats were placed prone on an operating
table covered by a warming blanket to maintain the body
temperature at 37.0 ± 0.50°C, and then were underwent
the laminectomy at the T10 level. The spinal cord was
hemisected with microscissors under an operating
microscope. The microscissors were inserted into the
spinal cord with the tip touching the midline until the
left side of the cord was completely divided. To inhibit the
immunological rejection, the immunosuppressive agent,
known as ciclosporin A (5 mg/ml), was administered in-
traperitoneally 2 days before cell transplantation. The ad-
ministration continued (once a day) until the animals
were sacrificed.
Cell transplantation
After cord hemisection, rats were randomly received
OECs treatment (n = 5), or normal saline administration
(SCI Group, n = 5). And other five rats were underwent
neither SCI nor transplant injections (Sham Group, n = 5).
Using microscopic visualization, 5 μl OECs at a concentra-
tion of 3 × 106/ml were injected into the spinal cord
around the injury site. The sham group rats were under-
went laminectomies only without SCI or transplant injec-
tions. After injection, the superficial back muscles and the
skin were sutured along the midline. All the operated rats
were allowed to recover spontaneously, besides the admin-
istration of penicillin for 3 days.
Behavior test: the nociceptive sensory assessment
One month after cells injection, sensation of each group
on the mechanical and thermal stimulation was assessed.
Hind paw sensitivity to innocuous mechanical stimu-
lation was evaluated by ANALGESY METER (UGO
BASILE, Italy, 37215). According to the previous de-
scription of Randall and Selitto [30], the nociceptive
thresholds (also called paw withdrawal threshold, PWT),
expressed in grams, were measured by applying an in-
creasing pressure to the hind paw until withdrawal. The
cut-off point was set to 500 g for preventing the damage.
Thermal hyperalgesia was measured by the Plantar
Analgesia Meter (UGO BASILE, Italy, 7370) according
to the method described by Hargreaves et al. [31]. Briefly,
the rats were placed in transparent plastic enclosures on a
glass plate, then acclimatized to test environment for
1 hour. A fixed intensity (intensity 80) and movable radi-
ant heat source was placed underneath the plate and
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nociceptive endpoint was obvious withdrawal of the hind
paws and the paw withdrawal latency (PWL) was
recorded. An automatic 20 s cutoff was used to prevent
tissue damage.
Sample harvested and observation of OECs in vivo
After measurement of sensory function, all rats for immu-
nohistochemistry were sacrificed and the spinal cords
were harvested. Spinal cords were sectioned by using
microtome (Leica, Germany) into 20 μm thickness sec-
tions. To detect the survival of OECs in host spinal cord,
the OECs derived from GFP transgenic mice around the
lesion site in the spinal cord was observed by immuno-
fluorescent microscope. The samples for RT-PCR were
harvested from different time point on the 1st, 3rd, 14th,
21st, 28th day after the operation or OECs administration;
while the spinal cords for Western Blot were collected
from the time point on the 14th day and 21st day.
Immunofluorescent observation and double labeling
in vivo
To detect the survival of OECs in the spinal cord, the
spinal cords were sectioned (20 μm), and then observed
under fluorescent microscope. To detect whether or not
transplanted OECs could express BDNF, and the host
neurons in the spinal could express BDNF and its func-
tional receptor TrkB, we performed immunofluorescent
staining. Briefly, sections were blocked with 3% goat
serum in TBS, then incubated overnight with anti-TrkB
(mouse, 1:400, MILLIPORE), anti-NeuN (mouse, 1:500,
MILLPORE), or anti-BDNF (rabbit, Chemicon, 1:500) at
4°C. After washing three times, secondary antibodies
conjugated to the fluorescent markers (anti-rabbit Cy-3,
red light, 1:100; anti-mouse 488: green) were used for
24 h incubation at 4°C. Lastly, the sections were observed
under fluorescent microscope after washing three times.
The control sections were incubated lonely in PBS, and
there is no positive staining.
RT-PCR
The tissues from the injury segments of OECS group,
operated group, and sham group were collected and
homogenized, respectively (the 1st, 3rd, 14th, 21st, 28th
day). The supernatant was obtained from the spinal cord
of each group, followed by a centrifugation (12,000/g).
By using Nanodrop spectrophotometer (ND-1000), the
concentrations of RNA samples were measured. The
equal amount of RNA (4lg) was used for each experiment.
Using the β-actin as the internal control, the RT-PCR
technique was performed to determine the level of BDNF
mRNA. Gene primers were synthesized by TaKaRa Com-
pany (Japan). The primer sequences for the upstream and
downstream of BDNF are respectively: 5′ TCCCTGGCTGACACTTTT 3′, 5′ ATTGGGTAGTTCGGCATT 3′ (the
bp is 466 bp), while for β-actin is : 5′GTAAAGACCTC
TATGCCAACA 3′, 5′ GGACTCATCGTACTCCTGCT
3′(the bp is 227 bp). By using Revert AidTM First Strand
cDNA Synthesis Kit (Fermentas, USA), the first strand
cDNA synthesis was prepared from 4 μg of total RNA in
order to amplify RNA. Then the PCR was performed with
the PCR MasterMix Kit (Fermentas, USA). The whole
process for 30 cycles included denaturation for 1 min at 94°C,
annealing for 1 min, and extension for 1 min at 72°C.
Subsequently the products of PCR were electrophoresed
in 1% agarose gel, stained with ethidium bromide, and
then visualized by ultraviolet gel imager (BioRad, USA).
The optical density (OD) of each product band which con-
sists of objective gene and β-actin was obtained, and then
the OD ratio between objective genes and β-actin were
calculated to quantify the relative OD values.
Western blot analysis
The tissues from the injury segments in OECs group,
operated group and sham one on the 14th day, and the
21st day were harvested respectively. After homogenized
with ice-cold PBS and lysed for 5 min in lysis buffer
(Pierce), the tissues were centrifuged (12,000/g), the
supernatant was collected. The protein concentrations of
the supernatants were tested by applying the micro
bicinchoninic acid (BCA) method. Equal amounts of
protein (20 μg) were denatured by boiling 5 min in
Laemmeli buffer, separated by 12% SDS-polyacrylamide,
and transferred onto nitrocellulose membrane. And the
membranes were blocked with low-fat milk in Tris-
buffered saline and incubated with primary antibodies
against rabbit p-ERK (1:500, cell signal) or ERK (1:1000,
cell signal). After incubating with HRP-conjugated sec-
ondary antibodies (goat anti-rabbit IgG, 1:5000), the la-
beling was detected using chemiluminescence reagents.
To determine the level of ERK and p-ERK, β-actin was
used as internal control. All pictures were collected and
the bands were measured by expressing as optical dens-
ities. Then the target band and β-actin ratio was counted
and used for the statistic analysis.
Statistical analysis
Quantitative variations were evaluated by mean ± SD.
Data were analyzed using one-way ANOVA by SPSS
software package after a suitable correction. The statistical
significance was defined as P < 0.05.
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